Rezolute (RZLT) Total Current Liabilities (2011 - 2026)

Rezolute recorded quarterly Total Current Liabilities of $7.7 million in Q1 2026, down 18.91% quarter-over-quarter from $9.5 million in Q4 2025, and down 26.82% year-over-year from $10.5 million in Q1 2025.

Rezolute's Total Current Liabilities history runs 16 years deep, the most recent figure standing at $7.7 million for Q1 2026.

  • In Q1 2026, Total Current Liabilities fell 26.82% year-over-year to $7.7 million; the TTM figure through Mar 2026 stood at $7.7 million (down 26.82% YoY), while the FY2025 annual figure was $11.9 million, up 24.01% from the prior year.
  • Total Current Liabilities came in at $7.7 million for Q1 2026 at Rezolute, down from $9.5 million in the prior quarter.
  • In the past five years, Total Current Liabilities ranged from a high of $11.9 million in Q2 2025 to a low of $2.4 million in Q3 2022.
  • A 5-year average of $7.3 million and a median of $7.7 million in 2026 frame the typical range for Total Current Liabilities.
  • Across the five-year window, Total Current Liabilities jumped 196.42% in 2023 and slipped 26.82% in 2026, its largest moves.
  • Rezolute's Total Current Liabilities stood at $6.3 million in 2022, then gained by 27.11% to $8.0 million in 2023, then jumped by 32.47% to $10.6 million in 2024, then declined by 10.44% to $9.5 million in 2025, then dropped by 18.91% to $7.7 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods registered $7.7 million, $9.5 million, and $10.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 16.35 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 1.70 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 636.40 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 66.94 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 13.42 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 3.88 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 5.11 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 1.35 Bn
10 Rezolute 374.41 Mn 374.41 Mn - 7.70 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 7.70 Mn
Dec 31, 2025 9.50 Mn
Sep 30, 2025 10.21 Mn
Jun 30, 2025 11.91 Mn
Mar 31, 2025 10.53 Mn
Dec 31, 2024 10.61 Mn
Sep 30, 2024 8.00 Mn
Jun 30, 2024 9.61 Mn
Mar 31, 2024 6.96 Mn
Dec 31, 2023 8.01 Mn
Sep 30, 2023 7.20 Mn
Jun 30, 2023 5.20 Mn
Mar 31, 2023 4.40 Mn
Dec 31, 2022 6.30 Mn
Sep 30, 2022 2.43 Mn
Jun 30, 2022 2.46 Mn
Mar 31, 2022 2.90 Mn
Dec 31, 2021 6.40 Mn
Sep 30, 2021 2.60 Mn
Jun 30, 2021 1.97 Mn
Mar 31, 2021 3.59 Mn
Dec 31, 2020 2.74 Mn
Sep 30, 2020 2.92 Mn
Jun 30, 2020 3.23 Mn
Mar 31, 2020 3.53 Mn
Dec 31, 2019 5.54 Mn
Sep 30, 2019 5.52 Mn
Jun 30, 2019 8.38 Mn
Mar 31, 2019 6.62 Mn
Dec 31, 2018 2.98 Mn
Sep 30, 2018 7.34 Mn
Jun 30, 2018 6.25 Mn
Mar 31, 2018 4.37 Mn
Dec 31, 2017 2.25 Mn
Sep 30, 2017 1.69 Mn
Jun 30, 2017 1.77 Mn
Mar 31, 2017 2.02 Mn
Dec 31, 2016 1.67 Mn
Sep 30, 2016 1.49 Mn
Jun 30, 2016 1.73 Mn
Mar 31, 2016 2.42 Mn
Dec 31, 2015 2.49 Mn
Sep 30, 2015 1.96 Mn
Jun 30, 2015 1.71 Mn
Mar 31, 2015 1.80 Mn
Dec 31, 2014 2.37 Mn
Sep 30, 2014 892,908.00
Jun 30, 2014 964,040.00
Mar 31, 2014 2.86 Mn
Dec 31, 2013 6.54 Mn
Sep 30, 2013 5.68 Mn
Jun 30, 2013 5.27 Mn
Mar 31, 2013 5.12 Mn
Dec 31, 2012 24,470.00
Sep 30, 2012 15,643.00
Jun 30, 2012 2.36 Mn
Mar 31, 2012 8,852.00
Dec 31, 2011 1.40 Mn
Sep 30, 2011 5,499.00
Jun 30, 2011 11,657.00